Savara Reports Third Quarter 2024 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third ...
The American Journal of Managed Care4d
Fexagratinib in MS Shows Promise for Human Use
Previous research has highlighted the roles of the FGF, CSF, and VEGF signaling pathways in the pathology of MS. “In chronic ...
Armed robbery in Revesby5d
CSF Multi-omics Reveals Lipid Role in Stroke Recovery
This study is led by Professor Rong Hu's team from the Department of Neurosurgery and Key Laboratory of Neurotrama, Southwest Hospital, Third Military ...
EurekAlert!6d
CSF multi-omics of intracerebral hemorrhage from onset to reperfusion underscores lipid metabolism in functional outcome
In a paper published in Science Bulletin, multi-omics analyses comprising of lipidomics (439 lipids), sterolomics (22 ...
SynOx Therapeutics Further Strengthens Executive Team with Appointments of U.S.-Based Chief Medical Officer and Chief Commercial Officer
Additions of Elyse Seltzer, M.D., as CMO and Robert Francomano as CCO Strengthen Company’s Presence in the U.S.Seasoned Team to Drive Forward ...